Efficacy, Safety, and Immunogenicity of AVT02 With Moderate-to-Severe Chronic Plaque Psoriasis
Clinical trial NCT03849404 · COMPLETED
Trial details
- NCT number
- NCT03849404
- Sponsor
- Alvotech Swiss AG
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-20
- Primary completion
- 2019-12-23
- Enrollment
- 413
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.